Wang, R., Chen, S., Huang, L., Zhou, Y., & Shao, Z. (2018). Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients with Triple‐Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival. Oncologist.
Styl ChicagoWang, Ruo‐Xi, Sheng Chen, Liang Huang, Ying Zhou, a Zhi‐Ming Shao. "Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients With Triple‐Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival." Oncologist 2018.
Citace podle MLAWang, Ruo‐Xi, et al. "Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients With Triple‐Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival." Oncologist 2018.